Skip to main content
NCBI home page
Critical Care logoLink to Critical Care
. 2012 Jun 7;16(Suppl 2):A21. doi: 10.1186/cc11279

Hypothermia in cardiogenic shock

Jesper van der Pals 1,✉
PMCID: PMC3389481

Cardiogenic shock is a state of inadequate systemic tissue perfusion, despite adequate left ventricular filling pressure. It is caused by extensive myocardial damage and appears to be aggravated by a systemic inflammatory response [1-4]. The result is hypotension with metabolic acidosis and often a fatal outcome. The condition affects approximately 5% of the patients with myocardial infarction, and carries a dismal prognosis if it prevails after reperfusion.

Therapeutic hypothermia has several properties of potential benefit in cardiogenic shock: Experiments with isolated myofibrils, papillary muscles and cross-circulated hearts have demonstrated that mild hypothermia increases myocardial contractility [5-7]. In the in vivo heart, mild hypothermia has been found to increase stroke volume and cardiac output [6,8].

The increase in contractility is considered to be mediated by an increased myofilament sensitivity to existing Ca2+, without a corresponding increase in myocardial oxygen consumption [9]. Moreover, hypothermia reduces the metabolic rate with 5 to 7%/°C [10,11], thereby reducing the demand on the circulation from the peripheral tissues. In an experimental setting, it also has the ability to reduce infarct size if applied prior to reperfusion [12,13].

In dog-based and porcine-based models of cardiogenic shock secondary to ischemia, therapeutic hypothermia has improved hemodynamic and metabolic parameters, and reduced mortality [14,15]. No randomized controlled trials of therapeutic hypothermia in cardiogenic shock in humans exist, but case series indicate that the effects observed in animal experiments can be reproduced [16-19].

In conclusion, therapeutic hypothermia is a promising treatment option for patients in cardiogenic shock that warrants further investigation.

References

  1. Hochman JS. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation. 2003;107:2998–3002. doi: 10.1161/01.CIR.0000075927.67673.F2. [DOI] [PubMed] [Google Scholar]
  2. Kaluski E, Hendler A, Blatt A, Uriel N. Nitric oxide synthase inhibitors in post-myocardial infarction cardiogenic shock - an update. Clin Cardiol. 2006;29:482–488. doi: 10.1002/clc.4960291103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cotter G, Berger PB. Cardiogenic shock - beyond the large infarction. Crit Care Med. 2006;34:2234–2235. doi: 10.1097/01.CCM.0000229671.12922.27. [DOI] [PubMed] [Google Scholar]
  4. Geppert A, Dorninger A, Delle-Karth G, Zorn G, Heinz G, Huber K. Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction. Crit Care Med. 2006;34:2035–2042. doi: 10.1097/01.CCM.0000228919.33620.D9. [DOI] [PubMed] [Google Scholar]
  5. Bjornstad H, Tande PM, Refsum H. Mechanisms for hypothermia-induced increase in contractile force studied by mechanical restitution and post-rest contractions in guinea-pig papillary muscle. Acta Physiol Scand. 1993;148:253–264. doi: 10.1111/j.1748-1716.1993.tb09556.x. [DOI] [PubMed] [Google Scholar]
  6. Weisser J, Martin J, Bisping E, Maier LS, Beyersdorf F, Hasenfuss G, Pieske B. Influence of mild hypothermia on myocardial contractility and circulatory function. Basic Res Cardiol. 2001;96:198–205. doi: 10.1007/s003950170071. [DOI] [PubMed] [Google Scholar]
  7. Mattheussen M, Mubagwa K, Van Aken H, Wusten R, Boutros A, Flameng W. Interaction of heart rate and hypothermia on global myocardial contraction of the isolated rabbit heart. Anesth Analg. 1996;82:975–981. doi: 10.1097/00000539-199605000-00015. [DOI] [PubMed] [Google Scholar]
  8. Nishimura Y, Naito Y, Nishioka T, Okamura Y. The effects of cardiac cooling under surface-induced hypothermia on the cardiac function in the in situ heart. Interact Cardiovasc Thorac Surg. 2005;4:101–105. doi: 10.1510/icvts.2004.097188. [DOI] [PubMed] [Google Scholar]
  9. Suga H, Goto Y, Igarashi Y, Yasumura Y, Nozawa T, Futaki S, Tanaka N. Cardiac cooling increases Emax without affecting relation between O2 consumption and systolic pressure-volume area in dog left ventricle. Circ Res. 1988;63:61–71. doi: 10.1161/01.res.63.1.61. [DOI] [PubMed] [Google Scholar]
  10. Polderman KH. Mechanisms of action, physiological effects, and complications of hypothermia. Critical Care Med. 2009;37:S186–S202. doi: 10.1097/CCM.0b013e3181aa5241. [DOI] [PubMed] [Google Scholar]
  11. Polderman KH. Application of therapeutic hypothermia in the intensive care unit. Opportunities and pitfalls of a promising treatment modality - Part 2: practical aspects and side effects. Intensive Care Med. 2004;30:757–769. doi: 10.1007/s00134-003-2151-y. [DOI] [PubMed] [Google Scholar]
  12. Gotberg M, Olivecrona GK, Koul S, Carlsson M, Engblom H, Ugander M, van der Pals J, Algotsson L, Arheden H, Erlinge D. A pilot study of rapid cooling by cold saline and endovascular cooling before reperfusion in patients with ST-elevation myocardial infarction. Circ Cardiovasc Interv. 2010;3:400–407. doi: 10.1161/CIRCINTERVENTIONS.110.957902. [DOI] [PubMed] [Google Scholar]
  13. Götberg M M, Olivecrona GK, Engblom H, Ugander M, van der Pals J, Heiberg E, Arheden H, Erlinge D. Rapid short-duration hypothermia with cold saline and endovascular cooling before reperfusion reduces microvascular obstruction and myocardial infarct size. BMC Cardiovasc Disord. 2008;8:7. doi: 10.1186/1471-2261-8-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gotberg M, van der Pals J, Olivecrona GK, Koul S, Erlinge D. Mild hypothermia reduces acute mortality and improves hemodynamic outcome in a cardiogenic shock pig model. Resuscitation. 2010;81:1190–1196. doi: 10.1016/j.resuscitation.2010.04.033. [DOI] [PubMed] [Google Scholar]
  15. Boyer NH, Gerstein MM. Induced hypothermia in dogs with acute myocardial infarction and shock. J Thorac Cardiovasc Surg. 1977;74:286–294. [PubMed] [Google Scholar]
  16. Skulec R, Kovarnik T, Dostalova G, Kolar J, Linhart A. Induction of mild hypothermia in cardiac arrest survivors presenting with cardiogenic shock syndrome. Acta Anaesthesiol Scand. 2008;52:188–194. doi: 10.1111/j.1399-6576.2007.01510.x. [DOI] [PubMed] [Google Scholar]
  17. Hovdenes J, Laake JH, Aaberge L, Haugaa H, Bugge JF. Therapeutic hypothermia after out-of-hospital cardiac arrest: experiences with patients treated with percutaneous coronary intervention and cardiogenic shock. Acta Anaesthesiol Scand. 2007;51:137–142. doi: 10.1111/j.1399-6576.2006.01209.x. [DOI] [PubMed] [Google Scholar]
  18. Yahagi N, Kumon K, Watanabe Y, Tanigami H, Haruna M, Hayashi H, Imanaka H, Takeuchi M, Ohashi Y, Takamoto S. Value of mild hypothermia in patients who have severe circulatory insufficiency even after intra-aortic balloon pump. J Clin Anesth. 1998;10:120–125. doi: 10.1016/S0952-8180(97)00255-9. [DOI] [PubMed] [Google Scholar]
  19. Moriyama Y, Iguro Y, Shimokawa S, Saigenji H, Toyohira H, Taira A. Successful application of hypothermia combined with intra-aortic balloon pump support to low-cardiac-output state after open heart surgery. Angiology. 1996;47:595–599. doi: 10.1177/000331979604700608. [DOI] [PubMed] [Google Scholar]

Articles from Critical Care are provided here courtesy of BMC

RESOURCES